NBEO Systemic Disease Practice Exam 2025 – All-in-One Guide to Mastering Systemic Disease!

The recommended dose of aspirin to be administered immediately for a myocardial infarction is 325 mg. This higher dose is particularly important in the acute setting because aspirin functions as an antiplatelet agent, which inhibits platelet aggregation and can help prevent further clot formation in the coronary arteries.

Administering 325 mg can quickly provide significant antiplatelet effects, which are crucial during a myocardial infarction when rapid action is necessary to reduce the risk of heart damage and improve patient outcomes. This dosing is consistent with established guidelines to ensure effective management of myocardial infarction.

Lower doses, such as 81 mg or 162 mg, are typically utilized for maintenance therapy after the acute phase has passed or for patients at risk of cardiovascular events but are not adequate for the immediate treatment of an ongoing myocardial infarction. The 650 mg option is not standard practice for this acute intervention and can lead to unnecessary side effects without providing a benefit in terms of managing myocardial ischemia.